# HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/hba1c-change-and-diabetic-retinopathy-during-glp-1-receptor-agonist/

## Facts

| Field | Value |
| --- | --- |
| Author Names | M. Angelyn Bethel,Rafael Díaz,Noelia Castellana,Indranil Bhattacharya,Hertzel C. Gerstein,Mark Lakshmanan |
| Citations | 144 |
| DOI | 10.2337/dc20-1815 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://diabetesjournals.org/care/article-pdf/44/1/290/532228/dc201815.pdf |
| OpenAlex ID | https://openalex.org/W3114565741 |
| PMID | 33444163 |
| Type | review |
| Year | 2020 |

## Paper authors

- [Mark Lakshmanan](https://scholariq.org/researchers/mark-lakshmanan/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Retinal Imaging and Analysis](https://scholariq.org/topics/retinal-imaging-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.